Involvement of FHIT in lung carcinogenesis prospects for future clinical gene therapy applications

Suppl Tumori. 2002 Jul-Aug;1(4):S62.

Authors

Gabriella Sozzi¹, Francesca Andriani, Marcella Gramegna, Luca Roz

Affiliation

¹ Molecular Cytogenetic Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy.

PMID: 12415825

No abstract available

Publication types

Review

MeSH terms

Acid Anhydride Hydrolases*
Adenoviridae / genetics
Animals
Apoptosis / physiology
Carcinoma, Non-Small-Cell Lung / genetics
Carcinoma, Non-Small-Cell Lung / therapy*
Cell Division / physiology
Disease Progression
Genes, Tumor Suppressor / physiology
Genetic Therapy*
Humans
Lung Neoplasms / genetics
Lung Neoplasms / therapy*
Mice
Mice, Nude
Neoplasm Proteins / physiology*
Neoplasm Transplantation
Neoplasms, Experimental / genetics
Neoplasms, Experimental / therapy*

Substances

Neoplasm Proteins
fragile histidine triad protein
Acid Anhydride Hydrolases